200-LB: Pregestational Diabetes and Pregnancy Outcomes
| العنوان: | 200-LB: Pregestational Diabetes and Pregnancy Outcomes |
|---|---|
| المؤلفون: | Mensud Hatunic, Dalal S.A. Ali |
| المصدر: | Diabetes. 68 |
| بيانات النشر: | American Diabetes Association, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Pregnancy, Type 1 diabetes, medicine.medical_specialty, endocrine system diseases, business.industry, Obstetrics, Endocrinology, Diabetes and Metabolism, nutritional and metabolic diseases, Type 2 diabetes, Hypoglycemia, Overweight, medicine.disease, Miscarriage, Diabetes mellitus, Cohort, Internal Medicine, medicine, medicine.symptom, business |
| الوصف: | Pre-gestational diabetes, type 1 diabetes (T1DM) and type 2 diabetes (T2DM) are associated with adverse outcomes: miscarriage, stillbirth, macrosomia and increased rates of emergency cesarean sections (EMCS). We reviewed 175 women with pre-gestational diabetes who attended the National Maternity Hospital in Dublin, Ireland between 2015 to 2017. Fifty women (28.6%) had T2DM and 125 women (71.4%) had T1DM. The mean age for T1DM group was (34 ± 4.7years) and T2DM (35.5 ± 3.8 years). Most of our patients were of European descent (85%) others were mostly of Asian and North African origin (15%). Mean duration of diabetes was 5.4 years in T2DM and 15.7 years in T1DM. Structured pre-pregnancy planning attended by 38.3% of our patients. Pre-pregnancy folic acid was used by 45.7% of patients for at least one month prior to booking. Forty women (29%) of T1DM were on Continuous Subcutaneous Insulin Infusion (CSII). Patients with T2DM were treated with Metformin (20%) only, Metformin and multiple dose insulin (MDI) injection combined (44%), MDI (28%) and diet control alone (2%). Mean BMI for T2DM was 32.6 ± 8.1 kg/m2 at booking and for T1DM 26.2 ± 4.5 kg/m2. Diabetic Retinopathy was more frequent in T1DM. The HBA1C in CSII group was 53.5 mmol/mol in the first trimester and improved to 42.9 mmol/mol in the third. T1DM group on MDI had HBA1C of 56.9 mmo/mol at booking and 44.7 mmol/mol in the third trimester. The mean HBA1C in T2DM at booking was 44.5 mmol/mol and 37.5 mmol/mol in the third trimester. Cesarean section (CS) was common in T1DM 48% with mostly EMCS 32%. In T2DM rate of CS was 38%. The most neonatal ICU (NICU) admission was due to hypoglycemia; in the T1DM group was 16.5% and 10% in T2DM group. Total neonatal birth weights above 4.0 Kg in our cohort was 21.7%. Our cohort with pre-gestational diabetes were overweight, older with long standing diabetes. Initial inadequate diabetes control in T1DM was better in patients with CSII with a significant improvement during pregnancy in all patients. With appropriate multidisciplinary treatment we minimized adverse outcomes. Disclosure D.S.A. Ali: None. M. Hatunic: None. |
| تدمد: | 1939-327X 0012-1797 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::91172d46a980d1380cbc2c4b4a4184a1Test https://doi.org/10.2337/db19-200-lbTest |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi...........91172d46a980d1380cbc2c4b4a4184a1 |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi...........91172d46a980d1380cbc2c4b4a4184a1 831 3 unknown 830.75439453125 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........91172d46a980d1380cbc2c4b4a4184a1&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
|
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => 200-LB: Pregestational Diabetes and Pregnancy Outcomes
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Mensud+Hatunic%22">Mensud Hatunic</searchLink><br /><searchLink fieldCode="AR" term="%22Dalal+S%2EA%2E+Ali%22">Dalal S.A. Ali</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>Diabetes</i>. 68 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => American Diabetes Association, 2019. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2019 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Pregnancy%22">Pregnancy</searchLink><br /><searchLink fieldCode="DE" term="%22Type+1+diabetes%22">Type 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22endocrine+system+diseases%22">endocrine system diseases</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Obstetrics%22">Obstetrics</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%2C+Diabetes+and+Metabolism%22">Endocrinology, Diabetes and Metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22nutritional+and+metabolic+diseases%22">nutritional and metabolic diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Type+2+diabetes%22">Type 2 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22Hypoglycemia%22">Hypoglycemia</searchLink><br /><searchLink fieldCode="DE" term="%22Overweight%22">Overweight</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Miscarriage%22">Miscarriage</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+mellitus%22">Diabetes mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22Cohort%22">Cohort</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+Medicine%22">Internal Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Esymptom%22">medicine.symptom</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Pre-gestational diabetes, type 1 diabetes (T1DM) and type 2 diabetes (T2DM) are associated with adverse outcomes: miscarriage, stillbirth, macrosomia and increased rates of emergency cesarean sections (EMCS). We reviewed 175 women with pre-gestational diabetes who attended the National Maternity Hospital in Dublin, Ireland between 2015 to 2017. Fifty women (28.6%) had T2DM and 125 women (71.4%) had T1DM. The mean age for T1DM group was (34 ± 4.7years) and T2DM (35.5 ± 3.8 years). Most of our patients were of European descent (85%) others were mostly of Asian and North African origin (15%). Mean duration of diabetes was 5.4 years in T2DM and 15.7 years in T1DM. Structured pre-pregnancy planning attended by 38.3% of our patients. Pre-pregnancy folic acid was used by 45.7% of patients for at least one month prior to booking. Forty women (29%) of T1DM were on Continuous Subcutaneous Insulin Infusion (CSII). Patients with T2DM were treated with Metformin (20%) only, Metformin and multiple dose insulin (MDI) injection combined (44%), MDI (28%) and diet control alone (2%). Mean BMI for T2DM was 32.6 ± 8.1 kg/m2 at booking and for T1DM 26.2 ± 4.5 kg/m2. Diabetic Retinopathy was more frequent in T1DM. The HBA1C in CSII group was 53.5 mmol/mol in the first trimester and improved to 42.9 mmol/mol in the third. T1DM group on MDI had HBA1C of 56.9 mmo/mol at booking and 44.7 mmol/mol in the third trimester. The mean HBA1C in T2DM at booking was 44.5 mmol/mol and 37.5 mmol/mol in the third trimester. Cesarean section (CS) was common in T1DM 48% with mostly EMCS 32%. In T2DM rate of CS was 38%. The most neonatal ICU (NICU) admission was due to hypoglycemia; in the T1DM group was 16.5% and 10% in T2DM group. Total neonatal birth weights above 4.0 Kg in our cohort was 21.7%. Our cohort with pre-gestational diabetes were overweight, older with long standing diabetes. Initial inadequate diabetes control in T1DM was better in patients with CSII with a significant improvement during pregnancy in all patients. With appropriate multidisciplinary treatment we minimized adverse outcomes. Disclosure D.S.A. Ali: None. M. Hatunic: None. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1939-327X<br />0012-1797 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_________::91172d46a980d1380cbc2c4b4a4184a1" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_________::91172d46a980d1380cbc2c4b4a4184a1</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.2337/db19-200-lb" linkWindow="_blank">https://doi.org/10.2337/db19-200-lb</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => CLOSED ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi...........91172d46a980d1380cbc2c4b4a4184a1 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Pregnancy
[Type] => general
)
[1] => Array
(
[SubjectFull] => Type 1 diabetes
[Type] => general
)
[2] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[3] => Array
(
[SubjectFull] => endocrine system diseases
[Type] => general
)
[4] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[5] => Array
(
[SubjectFull] => Obstetrics
[Type] => general
)
[6] => Array
(
[SubjectFull] => Endocrinology, Diabetes and Metabolism
[Type] => general
)
[7] => Array
(
[SubjectFull] => nutritional and metabolic diseases
[Type] => general
)
[8] => Array
(
[SubjectFull] => Type 2 diabetes
[Type] => general
)
[9] => Array
(
[SubjectFull] => Hypoglycemia
[Type] => general
)
[10] => Array
(
[SubjectFull] => Overweight
[Type] => general
)
[11] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[12] => Array
(
[SubjectFull] => Miscarriage
[Type] => general
)
[13] => Array
(
[SubjectFull] => Diabetes mellitus
[Type] => general
)
[14] => Array
(
[SubjectFull] => Cohort
[Type] => general
)
[15] => Array
(
[SubjectFull] => Internal Medicine
[Type] => general
)
[16] => Array
(
[SubjectFull] => medicine
[Type] => general
)
[17] => Array
(
[SubjectFull] => medicine.symptom
[Type] => general
)
[18] => Array
(
[SubjectFull] => business
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => 200-LB: Pregestational Diabetes and Pregnancy Outcomes
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Mensud Hatunic
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Dalal S.A. Ali
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 06
[Type] => published
[Y] => 2019
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 1939327X
)
[1] => Array
(
[Type] => issn-print
[Value] => 00121797
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsair
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 68
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Diabetes
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |